menu

NEWS

Ceres Nanosciences adding manufacturing facility, 50 jobs to improve COVID-19 tests – Washington Business Journal

By Sara Gilgore  –  Staff Reporter, Washington Business Journal Mar 3, 2021 Updated 20 minutes ago Ceres Nanosciences Inc., a Manassas company working to improve diagnostic testing for the coronavirus, is expanding its footprint with a new manufacturing facility that more than doubles its capacity as it rides a wave of momentum made possible by the pandemic. The local firm, a 12-year-old George Mason University spinout, has taken over 12,000 square feet at Innovation Park in Prince William County, where it also maintains its headquarters. The manufacturing plant delivered in fewer than four months to both support the production its customers currently demand and accommodate...

READ MORE
Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

MANASSAS, Va. — February 17, 2021 — Ceres Nanosciences, a privately held company that makes innovative products to improve diagnostic testing, announced that it has completed the build-out of a new 12,000-square-foot Advanced Particle Manufacturing Plant in Innovation Park, Prince William County, Virginia.  The new facility will be capable of generating a supply of Ceres’ Nanotrap® Magnetic Virus Particles to enable more than 10 million COVID-19 tests per month, with room for added capacity in the future.  Nanotrap® Magnetic Virus Particles improve diagnostic testing for COVID-19 by eliminating the need for RNA extraction kits, reducing sample processing time, and improving the sensitivity of the downstream assays in...

READ MORE
Ceres Nanosciences Nabs $243K SBIR Grant to Adapt SNA Capture Tech for Portable Sequencing

Sep 28, 2020 – GenomeWeb NEW YORK – Ceres Nanosciences announced Monday it has won a $243,000 Phase I Small Business Innovation Research grant from the US Centers for Disease Control and Prevention. The Manassas, Virginia-based infectious disease testing firm will use the funding to adapt its Nanotrap virus particles to work with portable sequencing tools. These hydrogel nanoparticles house chemical affinity baits, providing an alternative to RNA extraction kits and could be used to build viral pathogen surveillance workflows. “We can increase the amount of genomic material that goes into the sequencers by 10-fold,” Ben Lepene, Ceres CTO, said...

READ MORE
Ceres Nanosciences Receives $6.5M NIH Award to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

MANASSAS, Va. — September 2, 2020 — Ceres Nanosciences, a privately held company that makes innovative products to improve diagnostic testing, announced it has been awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. The contract, for  $6.5 million, will support an expansion to increase the manufacturing capacity of Ceres’ Nanotrap® Virus Particles for COVID-19 tests. ​ Ceres’ Nanotrap Virus Particles improve diagnostic testing for SARS-CoV-2 by eliminating the need for RNA extraction kits, reducing sample processing time, and improving the sensitivity of the downstream assays in point-of-care systems and in high-throughput laboratory developed tests. ​ The RADx initiative...

READ MORE
Press Release – July 2, 2020   ​New preprint demonstrates a rapid and versatile method for improving detection of SARS-CoV-2

Ceres Nanosciences and its collaborators at George Mason University have developed a Nanotrap® particle method that significantly improves detection of SARS-CoV-2. In a preprint posted on June 25, 2020, the teams describe how Nanotrap particles enable a rapid method for capturing and concentrating heat-inactivated and infectious SARS-CoV-2.  The simple method described in the preprint takes as little as 10 minutes to prepare SARS-CoV-2 RNA for downstream testing and obviates the need for commercial nucleic acid extraction kits. Using contrived samples with heat-inactivated and infectious SARS-CoV-2, the authors demonstrated significant (5- to 25-fold) improvements in real-time RT-PCR detection of the virus...

READ MORE
Ceres Nanosciences Receives $225,000 NIH SBIR Phase I Grant to Improve Serum Quality for Cell and Tissue Engineering

MANASSAS, Va. — January 31, 2020 — Ceres Nanosciences, Inc. (Ceres) today announced it has been awarded a $225,000 Phase I SBIR grant from the NIH to apply the Nanotrap® technology for improved quality testing and for the decontamination of animal serum used in cell and tissue culture applications.   According to a 2019 Genetic and Engineering News report, the cell and tissue engineering market generated an estimated $9 billion in product sales in 2017(1).  Because animal serum is a source of many of the required nutrients and growth factors for cell and tissue manufacturing, it is a key supplement added to...

READ MORE
1 2 3 5
GreyBird Ventures

is named after the arctic tern, a bird that migrates 71,000 km annually. As they can live for 30 years, this is the lifetime equivalent of three trips to the moon and back. Not bad for a 100 gram bird. We strive to emulate its size to performance ratio as well as its global reach.

MEET THE PEOPLE

For additional information, please contact: greybird@greybirdventures.com

DISCLAIMER